Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non–muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?

Patients with high-risk non–muscle-invasive bladder cancer who underwent partial bacillus Calmette-Guérin (BCG) induction experienced similar outcomes to those who received complete BCG induction. Additional prospective trials are needed to determine how to maximize BCG utilization for the greatest number of patients during global shortages.